Volume 8 Supplement 1
Edited by Edited by John Mayer and Rob Layfield
The human genome encodes several ubiquitin-like (UBL) domain proteins (UDPs). Members of this protein family are involved in a variety of cellular functions and many are connected to the ubiquitin proteasome s...
Citation: BMC Biochemistry 2007 8(Suppl 1):S1
Huntington's disease and several of the spinocerebellar ataxias are caused by the abnormal expansion of a CAG repeat within the coding region of the disease gene. This results in the production of a mutant pro...
Citation: BMC Biochemistry 2007 8(Suppl 1):S2
A functional ubiquitin proteasome system is essential for all eukaryotic cells and therefore any alteration to its components has potential pathological consequences. Though the exact underlying mechanism is u...
Citation: BMC Biochemistry 2007 8(Suppl 1):S3
Renal cell carcinoma (RCC) accounts for approximately 2.6% of all cancers in the United States. While early stage disease is curable by surgery, the median survival of metastatic disease is only 13 months. In ...
Citation: BMC Biochemistry 2007 8(Suppl 1):S4
Multiple steps in the RANK-NF-κB signalling pathway are regulated by ubiquitylation. Mutations affecting different components of this pathway, including the ubiquitin binding p62 signalling adapter protein, ar...
Citation: BMC Biochemistry 2007 8(Suppl 1):S5
In a simplified view, members of the HECT E3 family have a modular structure consisting of the C-terminal HECT domain, which is catalytically involved in the attachment of ubiquitin to substrate proteins, and ...
Citation: BMC Biochemistry 2007 8(Suppl 1):S6
Muscle wasting, characterized by the loss of protein mass in myofibers, is in most cases largely due to the activation of intracellular protein degradation by the ubiquitin proteasome system (UPS). During the ...
Citation: BMC Biochemistry 2007 8(Suppl 1):S7
Tumor viruses are linked to approximately 20% of human malignancies worldwide. This review focuses on examples of human oncogenic viruses that manipulate the ubiquitin system in a subset of viral malignancies;...
Citation: BMC Biochemistry 2007 8(Suppl 1):S8
Recently, the ubiquitin proteasome system (UPS) has matured as a drug discovery arena, largely on the strength of the proven clinical activity of the proteasome inhibitor Velcade in multiple myeloma. Ubiquitin...
Citation: BMC Biochemistry 2007 8(Suppl 1):S9
Fanconi anemia (FA) is a rare genetic disorder characterized by aplastic anemia, cancer/leukemia susceptibility and cellular hypersensitivity to DNA crosslinking agents, such as cisplatin. To date, 12 FA gene ...
Citation: BMC Biochemistry 2007 8(Suppl 1):S10
CF is an inherited autosomal recessive disease whose lethality arises from malfunction of CFTR, a single chloride (Cl-) ion channel protein. CF patients harbor mutations in the CFTR gene that lead to misfolding o...
Citation: BMC Biochemistry 2007 8(Suppl 1):S11
Though Alzheimer's disease (AD) is a syndrome with well-defined clinical and neuropathological manifestations, an array of molecular defects underlies its pathology. A role for the ubiquitin proteasome system ...
Citation: BMC Biochemistry 2007 8(Suppl 1):S12
Parkinson's disease (PD) is the most common neurodegenerative movement disorder. Although a subject of intense research, the etiology of PD remains poorly understood. Recently, several lines of evidence have i...
Citation: BMC Biochemistry 2007 8(Suppl 1):S13
Deregulation of the ubiquitin proteasome system (UPS) has been implicated in the pathogenesis of many human diseases, including cancer and neurodegenerative disorders. The recent approval of the proteasome inh...
Citation: BMC Biochemistry 2007 8(Suppl 1):S14